Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus

Circulation. 2020 Apr 14;141(15):1235-1237. doi: 10.1161/CIRCULATIONAHA.120.045864. Epub 2020 Apr 13.

Authors

Christopher B Granger¹, Kenneth W Mahaffey²

Affiliations

¹ Duke Clinical Research Institute, Durham, NC (C.B.G.).
² The Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.).

PMID: 32282249
DOI: 10.1161/CIRCULATIONAHA.120.045864

No abstract available

Keywords: Editorials; atrial fibrillation; diabetes mellitus, type 2; heart failure; sodium-glucose cotransporter 2 inhibitors.

Publication types

Editorial
Comment

MeSH terms

Atrial Fibrillation* / complications
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / drug therapy
Benzhydryl Compounds
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / diagnosis
Diabetes Mellitus, Type 2* / drug therapy
Glucosides
Humans

Substances

Benzhydryl Compounds
Glucosides
dapagliflozin